Evidence map›Paper›PMID 39985376›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Hybrid EMT Phenotype and Cell Membrane Tension Promote Colorectal Cancer Resistance to Ferroptosis.

Xiaowei Wei, Yutong Ge, Yaolin Zheng, Sunyan Zhao, Yuhan Zhou, Yuhan Chang, Nuofan Wang, Xiumei Wang, Juan Zhang, Xuanchang Zhang and 3 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Xiaowei WeiDepartment of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
Yutong GeDepartment of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
Yaolin ZhengDepartment of Respiratory, Critical Care and Sleep Medicine, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361102, China.
Sunyan ZhaoDepartment of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
Yuhan ZhouDepartment of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
Yuhan ChangCancer Center, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Nuofan WangSchool of Medicine, Southeast University, Nanjing, 210009, China.
Xiumei WangDepartment of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
Juan ZhangDepartment of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
Xuanchang ZhangDepartment of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.
Liqiao HuGuangzhou National Laboratory, Guangzhou, 510005, China.
Youhua TanThe Hong Kong Polytechnic University, Shenzhen Research Institute, Shenzhen, 518000, China.
Qiong JiaDepartment of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China.ORCID https://orcid.org/0009-0009-8110-5421

Funding

Health and Medical Research Fund HMRF18191421Hong Kong Research Grant Council 15227523Hong Kong Research Grant Council C5016-23GNational Natural Science Foundation of China 11972316National Natural Science Foundation of China 32000496National Natural Science Foundation of China 82103576National Natural Science Foundation of China 82473435Natural Science Foundation of Jiangsu Province BK20231127Shenzhen Science and Technology Innovation Program JCYJ20200109142001798Shenzhen Science and Technology Innovation Program JCYJ20220531091002006
6 · The paper itself

Abstract

Intratumoral heterogeneity, including epithelial-mesenchymal transition (EMT), is one major cause of therapeutic resistance. The induction of ferroptosis, an iron-dependent death, has the potential in overcoming this resistance to traditional treatment modalities. However, the roles of distinct EMT phenotypes in ferroptosis remain an enigma. This study reports that 3D soft fibrin microenvironment confers colorectal cancer (CRC) cells hybrid EMT phenotype and high level of resistance to ferroptosis. The activation of histone acetylation and WNT/β-catenin signaling drives this EMT phenotypic transition, which promotes the defense of 3D CRCs against ferroptosis via glutathione peroxidases/ferritin signaling axis. Unexpectedly, E-cadherin knockout in 3D but not 2D CRCs mediates an integrin β

Indexed as

Cell MembraneColorectal NeoplasmsDrug Resistance, NeoplasmEpithelial-Mesenchymal TransitionFerroptosisAnimalsCadherinsCell Line, TumorHumansMicePhenotypeTumor MicroenvironmentWnt Signaling PathwayCadherinscolorectal cancerferroptosishybrid EMTmembrane tensionphysical environment

Identifiers

PMID39985376
PMCPMC12005738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.